Washington Capital Management’s Abiomed Inc ABMD Stock Holding History

Washington Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,500	Closed	-$267K	–	106
2019 Q3	$267K	Hold	1,500	–	–	0.26%	88
2019 Q2	$391K	Buy	1,500 +450	+43%	+$119K	0.44%	67
2019 Q1	$300K	Hold	1,050	–	–	0.34%	91
2018 Q4	$341K	Hold	1,050	–	–	0.4%	82
2018 Q3	$472K	Sell	1,050 -250	-19%	-$98.5K	0.45%	69
2018 Q2	$532K	Sell	1,300 -700	-35%	-$254K	0.55%	43
2018 Q1	$582K	Hold	2,000	–	–	0.58%	39
2017 Q4	$375K	Hold	2,000	–	–	0.38%	79
2017 Q3	$337K	Hold	2,000	–	–	0.36%	82
2017 Q2	$287K	Hold	2,000	–	–	0.32%	86
2017 Q1	$250K	Hold	2,000	–	–	0.29%	94
2016 Q4	$225K	Sell	2,000 -1,300	-39%	-$151K	0.28%	94
2016 Q3	$424K	Buy	+3,300	New	+$395K	0.58%	58

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Washington Capital Management's ABMD Position: Q4 2019 in Review

Washington Capital Management sold out of Abiomed Inc (ABMD) in Q4 2019, closing a stake of 1,500 shares — an estimated $267K sold.

Washington Capital Management first reported a position in ABMD in Q3 2016 and held it in 13 quarters. The position peaked at $582K in Q1 2018. 465 funds tracked by Wall St. Rank hold ABMD as of Q4 2019.

Washington Capital Management reported no remaining Abiomed Inc position as of Q4 2019 after selling out during the quarter.
Washington Capital Management sold 1,500 Abiomed Inc shares in Q4 2019, an estimated $267K.
Washington Capital Management first reported a position in Abiomed Inc in Q3 2016 and held it in 13 quarters.
Washington Capital Management's Abiomed Inc position peaked at $582K in Q1 2018.
465 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2019.

Based on Washington Capital Management's 13F filing for Q4 2019, filed 7 Feb 2020.